Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients

Author(s):  Sturn Kayla M, Collin Michael

Issue:  May/Jun 2016 - Volume 20, Number 3
View All Articles in Issue

Page(s):  197-201

Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Page 1
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Page 2
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Page 3
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Page 4
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Page 5

Download in electronic PDF format for $75

Abstract:  Naltrexone (an opioid antagonist) has long been used in patients overcoming alcohol and opioid dependency. However, at doses one-tenth of those commonly prescribed for the above conditions, an unexpected effect occurs that aids in alleviating pain. Although there are currently no randomized clinical trials supporting the use of low-dose naltrexone, we present a case study describing the impact of compounding low-dose naltrexone that has dramatically improved the patient’s pain symptoms which were refractory to other treatments.

Related Keywords: Kayla M. Sturm, PharmD Candidate, Michael Collin, RPh, FIACP, low-dose naltrexone, opioid antagonist, complex regional pain syndrome type I, extremity pain, CRPS, chronic pain syndromes, neuropathic pain, patient distress, case study, adverse effects, drug interactions, formulation

Related Categories: FORMULATIONS, PAIN MANAGEMENT, CASE REPORTS, ADVERSE DRUG EVENTS, NEUROLOGY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients
Sturn Kayla M
, Collin Michael
May/Jun 2016
Pg. 197-201

Case Study: Personalized Oral Low-dose Naltrexone Titration for Pain Management
Rodriguez Franklin
, Carvalho Maria, Banov Fabiana
Nov/Dec 2023
Pg. 468-473

Topical Ketamine in the Treatment of Complex Regional Pain Syndrome
Durham Melissa J
, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H
Mar/Apr 2018
Pg. 172-175

Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report
Zur Eyal
Jan/Feb 2014
Pg. 14-19

Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report
Muller George
, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don
Jul/Aug 2018
Pg. 270-278

Oral Methadone for Management of Regional Sympathetic Dystrophy Syndrome: A Case Revisited
Vail Jane
May/Jun 2007
Pg. 187-192

Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott
, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2010
Pg. 182-192

Low-dose Naltrexone Therapy for Psoriasis
Weinstock Leonard B
, Cottel Jill, Aldridge Lindsey, Egeberg Alexander
Mar/Apr 2020
Pg. 94-96

The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia
Cote Brianna
, Ross Bethany, Fortner Jeff, Rao Deepa
May/Jun 2018
Pg. 252-256

Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders
Ploesser Jennifer
, Weinstock Leonard B, Thomas Erin
Mar/Apr 2010
Pg. 171-173

Burning Mouth Syndrome: A Discussion of a Complex Pathology
Zur Eyal
May/Jun 2012
Pg. 196-205

Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future
Rabi Joseph
Mar/Apr 2016
Pg. 107-113

Topical Medications for Orofacial Neuropathic Pain
Bramwell Bethany L
May/Jun 2010
Pg. 200-203

Opioids: A Review of the Pharmacology
Ford Peter R
Jan/Feb 2000
Pg. 17-20

Compounded Pain Formulations: What is the Evidence?
Asbill Scott
, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2014
Pg. 278-286

Compounded Pain Formulations: What is the Evidence?
Asbill Scott
, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2024
Pg. 100-109

Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M
, Rivera Gerard, Balthasar Jan, Florea Naomi
Jul/Aug 2015
Pg. 295-300

Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M
, Rivera Gerard, Balthasar Jan, Florea Naomi
Mar/Apr 2024
Pg. 111-116

Clinical Nuggets and Pearls: Chronic Neuropathic Pain and Opioid Tolerance
Jones Marty
Jan/Feb 2002
Pg. 4-6

Low-dose Pilocarpine Spray to Treat Xerostomia
Zur Eyal
Mar/Apr 2020
Pg. 104-108

Return to Top